Cypak Compliancy Connection Powers Stora Enso Pharma DDSi

Wednesday, November 21, 2007 General News J E 4
STOCKHOLM, November 20 Stora Enso, a leading producer ofpharmaceutical packaging boards, has launched Pharma DDSi , the firstintelligent pharmaceutical packaging solution to use Cypak's CompliancyConnection.

Compliancy Connection is a standard low-cost electronic module builtaround a single RFID microchip and is designed to be embedded inpharmaceutical packaging. Electronic sensors are printed onto the packagingto detect when a dose of medicine is removed.

Non-compliance is increasingly recognized as a major problem in healthcare. Experts believe that over 50% of people do not take their medication asprescribed, causing tens of thousands of avoidable admissions to hospitalsand care homes.

There are many reasons for non-compliancy. Memory lapses result in peopleskipping a dose or even taking multiple doses. Some people worry aboutside-effects, others misinterpret the instructions on how to take themedication. Sometimes children take medicines that are not intended for them,and older people struggle to open the packaging. Lack of objective compliancydata may even cause doctors to switch medication or increase dosage levelsunnecessarily.

Pharma DDSi is a holistic solution that improves compliancy, providingobjective data to caregivers and patients alike:

- Electronics embedded in the package provide reminders, recordmedication events, and transmit the medication history to the care-giver.

- A printed questionnaire captures the patient's feelings when takingmedication. Direct communication to a specialist warns of side-effects andenables early intervention.

- DDSi is a carton solution. Clear instructions for use are printed onthe packaging.

- Stora Enso also offers child resistant and senior friendly packagingsolutions.

Pharma DDSi works with a variety of database solutions includingPackAgent Compliance Monitoring software. This system is used for trackingand tracing the packages, capturing the compliance data and sharing results.

Per Nathanaelson, Cypak CEO, comments: "The low-cost electronic solutionprovided by Cypak, combined with Stora Enso's expertise, is further openingthe way for widespread global adoption of intelligent pharmaceuticalpackaging."

Ismo Saarinen, Director, Pharmaceutical Solutions, Stora Enso, comments:"Pharma DDSi is a ground breaking solution. Together with Cypak we willcontinue to drive innovation, affordability, and connectivity."

Links: and



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Genmab and GlaxoSmithKline Initiate Ofatumumab Rhe...
Cord Blood America Revenues Up 121 Percent in Firs...